Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3131 (LINC03131), also known as AL162413.1, is a human gene encoding a long non-coding RNA (lncRNA) transcript. It is located on chromosome 9 (locus: 9:10,948,281-11,065,127). LINC03131 is part of the large class of lincRNAs, which are RNA molecules greater than 200 nucleotides in length that do not code for proteins and are situated between protein-coding genes. As of current knowledge, there is no reported evidence that links LINC03131 to any characterized biological process or disease, nor evidence of its use as a therapeutic target. It is not classified as a receptor, enzyme, or any classical drug target category. No interacting drugs or clinical utility as a biomarker have been described. Its function, if any, remains to be elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3131 (LINC03131).